Letter: grouping traditional biomarkers that are within reach has great utility - further validation is needed

Rongtao Lai^{1

2}, Mindie H Nguyen^{1

3}

Affiliations

¹ Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA.
² Department of Infectious Diseases, Shanghai Jiaotong University School of Medicine, Ruijin Hospital, Shanghai, China.
³ Department of Epidemiology and Population Health, Stanford University, Palo Alto, California, USA.

Comment

Rongtao Lai et al. Aliment Pharmacol Ther. 2023 May.

. 2023 May;57(9):1050-1051.

doi: 10.1111/apt.17459.

Rongtao Lai^{1

2}, Mindie H Nguyen^{1

3}

¹ Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA.
² Department of Infectious Diseases, Shanghai Jiaotong University School of Medicine, Ruijin Hospital, Shanghai, China.
³ Department of Epidemiology and Population Health, Stanford University, Palo Alto, California, USA.

No abstract available

Comment on

Improved prediction of 10-year risk of severe liver disease in the general population using commonly available biomarkers.
Hagström H, Yan J, Talbäck M, Andreasson A, Walldius G, Bottai M, Hammar N. Hagström H, et al. Aliment Pharmacol Ther. 2023 Feb;57(4):418-425. doi: 10.1111/apt.17374. Epub 2022 Dec 25. Aliment Pharmacol Ther. 2023. PMID: 36566508 Free PMC article.

1. Hagstrom H, Yan J, Talback M, Andreasson A, Walldius G, Bottai M, et al. Improved prediction of 10-year risk of severe liver disease in the general population using commonly available biomarkers. Aliment Pharmacol Ther. 2023;57(4):418-25.
1. Ito T, Nguyen VH, Tanaka T, Park H, Yeh ML, Kawanaka M, et al. Poor diagnostic efficacy of noninvasive tests for advanced fibrosis in obese or younger than 60 diabetic NAFLD patients. Clin Gastroenterol Hepatol. 2022;30:S1542-3565(22)00525-0. https://doi.org/10.1016/j.cgh.2022.05.015
1. Hagstrom H, Talback M, Andreasson A, Walldius G, Hammar N. Ability of noninvasive scoring systems to identify individuals in the population at risk for severe liver disease. Gastroenterology. 2020;158(1):200-14.
1. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151-71.
1. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317-25.